You have Javascript disabled. Some elements of this page may not work as expected.
Hi, we've made some changes
Drugs group Shire generates almost half of its revenues from the attention deficit disorder treatment Adderall. Founded in 1986 the group became a listed company in 1996. Recently acquired TKT in the US and signed a collaboration deal with New River.
Div Yield
0.5%
0.6%
Div Cover
1.8
9.8
Op Mrgn
5.0%
24.3%
ROCE
24.9%
P/E
102.8
15.8
PEG
0.3
0.0
Pr/Revenue
3.6
3.0
Pr/Book
1.7
Revenue
35.6%
20.5%
PBT
-75.8%
2177.6%
EPS
393.5%
552.2%
DPS
20.1%
17.4%
31-Dec-03
1,211.57
406.35
55.40¢
19.4
n/a
n/a
n/a
0.0%
31-Dec-04
1,363.21
459.89
67.20¢
16.1
0.8
+21%
5.67¢
0.5%
31-Dec-05
1,599.30
(143.80)
(36.40)¢
n/a
n/a
n/a
6.24¢
0.4%
31-Dec-06
1,796.50
129.60
3.10¢
677.2
n/a
n/a
7.18¢
0.3%
31-Dec-07
2,436.30
31.40
15.30¢
148.9
0.4
+394%
8.62¢
0.4%
a. Based on UK GAAP presentation of accounts - includes discontinued activities
31-Dec-08
1,481.48 360.61
50.07p
15.8
0.0
+552%
5.10p
0.6%
31-Dec-09
1,491.32 366.95
50.88p
15.6
9.7
+2%
5.92p
0.7%
13-Jun-08
Buy
Angus Russell
804.35p 6,000
£48,260.74
Currency
UK Pounds
Share Price
793.00p
Change Today
-15.50p
52 Week High
1,310.00p
52 Week Low
775.00p
Volume
1,503,979
Shares Issued
559.88m
Market Cap
£4,439.85m
Beta
0.78
RiskGrade
166
Strong Buy
12
Buy
5
Neutral
7
Sell
3
Strong Sell
0
Total
27
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.
Final
Interim
Ex-Div
12-Mar-08
12-Sep-07
Paid
09-Apr-08
04-Oct-07
Amount
6.47¢
2.15¢
17:11
27,100 @ 793.56p
16:45
60,037 @ 792.68p
16:38
50,000 @ 797.91p
16:35
200,146 @ 793.00p
16:29
1,014 @ 795.00p
CEO
Angus Russell
CFO
Graham Hetherington
Please wait, loading...